Self-monitoring of blood pressure during pregnancy


Self-monitoring of blood pressure during pregnancy

The Blood Pressure management system BPm-Health allows pregnant women to accurately self-monitor blood pressure during pregnancy and enables healthcare professionals to provide remote care for mums-to-be.

The need for safe remote monitoring during the COVID-19 epidemic

There has been an increasing recognition of the benefits from self-monitoring of blood pressure (‘BP’) during pregnancy - see references below.  The COVID-19 outbreak is now increasing the need for healthcare professionals to advocate BP self-monitoring to reduce face-to-face consultations for pregnant and postnatal women whilst maintaining care for the woman and her baby.

Self-monitoring in pregnancy

Either to replace BP measurements on the day of a virtual clinic or so that BP measurements may be done more frequently.

Easy to use

Provide an accurate, easy to use system for women, many of whom already informally self-monitor.

Provides advice

Provides advice on what a woman should do depending on her BP levels.

BPm-Health is aimed at:


Women with chronic hypertension, gestational hypertension, pre-eclampsia


Women determined as high-risk by NICE guidelines


All pregnant women (including those who may need to self-isolate for a period)

NICE Guidelines:
One of  the following risk factors:
  • hypertensive disease during a previous pregnancy
  • chronic kidney disease
  • autoimmune disease (e.g. systemic lupus erythematosus orantiphospholipid syndrome)
  • type 1 or type 2 diabetes
Two of  the following risk factors:
  • first pregnancy
  • age 40 years or older
  • pregnancy interval of more than 10 years
  • body mass index (BMI) of 35 kg/m2 or more family history of pre-eclampsia
  • multi-fetal pregnancy
In partnership with
University of Oxford logo


Improves care
Improves care

Provides women with advice about blood pressure levels .

Gives control
Gives control

Self-management gives patients greater control of their blood pressure monitoring while reducing the need for clinical visits.

Provides reassurance
Provides reassurance

Helps mums-to-be self-monitor blood pressure to protect themselves and their baby.

Easy, accurate monitoring
Easy, accurate monitoring

Provides an easy to use and uniform monitoring system for women during pregnancy and healthcare professionals.

Increases safety
Increases safety

Reduces face-to-face contact to reduce risk associated with COVID-19 infection.


All patient data is anonymised, securely stored on the cloud as a completely isolated instance with rigorous data security and privacy measures.

BPm is currently in development phase prior to commercial launch following successful academic trials by the University of Oxford.


  1. McManus RJ, Mant J,Franssen M, Nickless A, Schwartz C, Hodgkinson J, et al. Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial. Lancet. 2018; 391(10124):949-59.

  2. McManusRJ, Mant J, Bray EP, Holder R, Jones MI, Greenfield S, et al. Telemonitoring and self-management in the control of hypertension (TASMINH2): a randomised controlled trial. Lancet. 2010; 376(9736):163-72.

  3. McManusRJ, Mant J, Haque MS, Bray EP, Bryan S, Greenfield SM, et al. Effect of self-monitoring and medication self-titration on systolic blood pressure in hypertensive patients at high risk of cardiovascular disease: the TASMIN-SR randomized clinical trial. JAMA. 2014;312(8):799-808.

  4. PealingLM, Tucker KL, Mackillop LH, Crawford C, Wilson H, Nickless A, et al. A randomised controlled trial of blood pressure self-monitoring in the management of hypertensive pregnancy. OPTIMUM-BP: A feasibility trial. Pregnancy Hypertens. 2019;18:141-9.

  5. Cairns AE, Tucker KL, Leeson P, Mackillop LH, Santos M, Velardo C, et al. Self-Management of Postnatal Hypertension: The SNAP-HT Trial. Hypertension.2018.

  6. TuckerKL, Taylor KS, Crawford C, Hodgkinson JA, Bankhead C, Carver T, et al. Blood pressure self-monitoring in pregnancy: examining feasibility in a prospective cohort study. BMC Pregnancy Childbirth. 2017;17(1):442.

  7. HintonL, Tucker KL, Greenfield SM, Hodgkinson JA, Mackillop L, McCourt C, et al.Blood pressure self-monitoring in pregnancy (BuMP) feasibility study; a qualitative analysis of women's experiences of self-monitoring. BMC PregnancyChildbirth. 2017;17(1):427.

  8. GrantS, Hodgkinson J, Schwartz C, Bradburn P, Franssen M, Hobbs FR, et al. Using mHealth for the management of hypertension in UK primary care: an embedded qualitative study of the TASMINH4 randomised controlled trial. Br J Gen Pract. 2019;69(686):e612-e20.

  9. JonesMI, Greenfield SM, Bray EP, Baral-Grant S, Hobbs FD, Holder R, et al. Patients' experiences of self-monitoring blood pressure and self-titration of medication: the TASMINH2 trial qualitative study. Br J Gen Pract. 2012;62(595):e135-e42.

  10. Tucker KL, Bowen L, Crawford C, Mallon P,Hinton L, Lee MM, et al. The feasibility and acceptability of self-testing for proteinuria during pregnancy: A mixed methods approach. Pregnancy Hypertens. 2018;12:161-8.